Sector ratings H. Lundbeck A/S

Equities

Delayed Nasdaq Copenhagen Other stock markets 16:20:00 13/05/2026 BST			5-day change	1st Jan Change
41.38 ^DKK	-0.43%		-2.77%	-4.12%

05-13	H Lundbeck: Strong Q1, but long-term growth uncertainty hovers over valuation
05-13	Nordea raises Lundbeck price target to DKK 57 (55), reiterates Buy	FW

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
H. LUNDBECK A/S	6.26B		BBB
MCKESSON CORPORATION	88.61B	-	AA	-		-
CARDINAL HEALTH, INC.	43.64B	-	AAA	-		-
SIGMA HEALTHCARE LIMITED	23.89B		AAA
HUADONG MEDICINE CO., LTD	8.59B		AA
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	8.41B		AA
SINOPHARM GROUP CO. LTD.	7.29B		BBB
GALENICA AG	5.22B		AAA
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	3.72B		BB
MEDIPAL HOLDINGS CORPORATION	3.6B		AA			-
CHINA NATIONAL MEDICINES CORPORATION LTD.	3.15B		BB			-
EBOS GROUP LIMITED	2.58B		AAA
CHINA MEHECO GROUP CO., LTD.	2.3B	-	-	-	-	-	-	-
SUZUKEN CO., LTD.	2.27B		AA			-
CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.	1.88B		-
SAUDI CHEMICAL HOLDING COMPANY	1.87B	-	BBB	-	-	-	-	-
QINGDAO BAHEAL MEDICAL INC.	1.81B	-	-	-		-
TOHO HOLDINGS CO., LTD.	1.69B		AA			-
C.Q. PHARMACEUTICAL HOLDING CO., LTD.	1.69B	-	-	-	-	-	-	-
SELÇUK ECZA DEPOSU TICARET VE SANAYI	1.51B		BB			-
Average	11B		AA
Weighted average by Cap.			AA